HK1046138A1 - 1,5-benzodiazepine derivatives - Google Patents

1,5-benzodiazepine derivatives

Info

Publication number
HK1046138A1
HK1046138A1 HK02107684.4A HK02107684A HK1046138A1 HK 1046138 A1 HK1046138 A1 HK 1046138A1 HK 02107684 A HK02107684 A HK 02107684A HK 1046138 A1 HK1046138 A1 HK 1046138A1
Authority
HK
Hong Kong
Prior art keywords
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
HK02107684.4A
Other languages
Chinese (zh)
Inventor
Colclough David
Hodgson Ann
Ryszard Szewczyk Jerzy
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910366.5A external-priority patent/GB9910366D0/en
Priority claimed from GBGB0008179.4A external-priority patent/GB0008179D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK1046138A1 publication Critical patent/HK1046138A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02107684.4A 1999-05-06 2002-10-23 1,5-benzodiazepine derivatives HK1046138A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9910366.5A GB9910366D0 (en) 1999-05-06 1999-05-06 1,5-Benzodiazepine Derivatives
GBGB0008179.4A GB0008179D0 (en) 2000-04-05 2000-04-05 Chemical process
PCT/EP2000/003982 WO2000068209A2 (en) 1999-05-06 2000-05-04 1,5-benzodiazepine derivatives as cck-a receptor agonists

Publications (1)

Publication Number Publication Date
HK1046138A1 true HK1046138A1 (en) 2002-12-27

Family

ID=26244033

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107684.4A HK1046138A1 (en) 1999-05-06 2002-10-23 1,5-benzodiazepine derivatives

Country Status (21)

Country Link
EP (1) EP1212305A2 (en)
JP (1) JP2002544200A (en)
KR (1) KR20020012567A (en)
CN (1) CN1161345C (en)
AR (1) AR022044A1 (en)
AU (1) AU4754800A (en)
BR (1) BR0010338A (en)
CA (1) CA2370801A1 (en)
CO (1) CO5170461A1 (en)
CZ (1) CZ20013988A3 (en)
HK (1) HK1046138A1 (en)
HU (1) HUP0201181A3 (en)
IL (1) IL146124A0 (en)
MX (1) MXPA01011267A (en)
MY (1) MY138319A (en)
NO (1) NO20015397L (en)
NZ (1) NZ515048A (en)
PE (1) PE20010110A1 (en)
PL (1) PL351546A1 (en)
TR (1) TR200103169T2 (en)
WO (1) WO2000068209A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
JP4069159B2 (en) 2004-05-25 2008-04-02 ファイザー・プロダクツ・インク Tetraazabenzo [e] azulene derivatives and analogs thereof
KR20220150270A (en) 2019-10-07 2022-11-10 칼리오페, 인크. GPR119 agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
NZ515048A (en) 2004-01-30
TR200103169T2 (en) 2002-04-22
AU4754800A (en) 2000-11-21
CN1161345C (en) 2004-08-11
IL146124A0 (en) 2002-07-25
NO20015397D0 (en) 2001-11-05
WO2000068209A2 (en) 2000-11-16
KR20020012567A (en) 2002-02-16
MY138319A (en) 2009-05-29
CN1362949A (en) 2002-08-07
EP1212305A2 (en) 2002-06-12
CO5170461A1 (en) 2002-06-27
MXPA01011267A (en) 2002-05-06
JP2002544200A (en) 2002-12-24
HUP0201181A3 (en) 2003-10-28
BR0010338A (en) 2002-02-13
CA2370801A1 (en) 2000-11-16
PL351546A1 (en) 2003-05-05
CZ20013988A3 (en) 2002-02-13
NO20015397L (en) 2001-11-05
PE20010110A1 (en) 2001-03-05
AR022044A1 (en) 2002-09-04
WO2000068209A3 (en) 2001-03-01
HUP0201181A2 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
HK1051037A1 (en) Benzodiazepine derivatives.
HK1051038A1 (en) Benzodiazepine derivatives.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
ZA200003927B (en) 1,2,4,5-tetrahydro-benzo[d]jazepines.
HK1041885A1 (en) Amide derivatives.
IL141226A0 (en) 1h-imidazopyridine derivatives
ZA99254B (en) Benzosulfone derivatives.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
GB9809664D0 (en) a-Ketoamide derivatives
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
HK1043998A1 (en) Piperazine derivatives.
HU9802807D0 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives
ZA991550B (en) Cyclohexanediole derivatives.
EG23802A (en) 2-Phenylpyran-4-one derivatives
IL136500A0 (en) 1,4-diazacycloheptane derivatives
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
GB9827729D0 (en) Thieno-indole derivatives
MXPA01011285A (en) Thio-oxindole derivatives.
HUP9902291A2 (en) New 2,3-benzodiazepine derivatives
IL146124A0 (en) 1,5-benzodiazepine derivatives
EP1061912A4 (en) Phenanthrofuran derivatives
IL139276A0 (en) Cyclohexenondioxthio chromanoyl derivatives
GB2350361B (en) 3,4,5-tricyanophenyl derivatives
GB9910366D0 (en) 1,5-Benzodiazepine Derivatives